Sandra Donnini

Associate Professor

University of Siena

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Research Cancer Research professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sandra Donnini is an Associate Professor at the University of Siena in Italy. Her research interests encompass various aspects of pharmacotherapy and cancer treatment, with a focus on the cardiovascular effects of nutraceuticals, COVID-19 patient outcomes, and the safety profiles of antiangiogenic drugs. She has authored several recent articles exploring drug utilization in cancer treatments, sex differences in pharmacotherapy, and the development of algorithms for cancer identification in pathology registries.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

CLAUDIO CUCINI

University of Siena

ITALY

View details

Francesco Dotta

ITALY

View details

Allison Singier

University of Bordeaux

FRANCE

View details

Elena Bargagli

ITALY

View details

Fabrizio Gemmi

Unit Chief

ITALY

View details

Ersilia Lucenteforte

Professoressa Associata

University of Pisa

ITALY

View details

Gianni Virgili

Professor

The Queen's University Belfast

UNITED KINGDOM

View details

Cristina Stasi

University of Siena

ITALY

View details

Emma Ristori

Yale University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sandra Donnini

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Citrus reticulata Olive Oil: Production and Nutraceutical Effects on the Cardiovascular System in an In Vivo Rat Model of Metabolic Disorder

Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results

ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling

Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies

Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis

Sex differences in the utilization of drugs for COVID‐19 treatment among elderly residents in a sample of Italian nursing homes

Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis?

Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry

First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective

Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data

Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells

By-Products from Winemaking and Olive Mill Value Chains for the Enrichment of Refined Olive Oil: Technological Challenges and Nutraceutical Features

Development of Fortified Citrus Olive Oils: From Their Production to Their Nutraceutical Properties on the Cardiovascular System

Collaborators (9)

CLAUDIO CUCINI

Francesco Dotta

Allison Singier

Elena Bargagli

Fabrizio Gemmi

Ersilia Lucenteforte

Gianni Virgili

Cristina Stasi

Emma Ristori

Make your next move.